Clinical Trial Detail

NCT ID NCT02428192
Title Nivolumab in Treating Patients With Advanced Uterine Leiomyosarcoma
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

uterus leiomyosarcoma

Therapies

Nivolumab

Age Groups: adult

No variant requirements are available.